An administration method is provided, in which a composition comprising a forskolin 1α,9α-carbonate compound is administered to a human subject. According to an embodiment, the forskolin 1α,9α-carbonate compound has a skeletal structure of 8,13-epoxy-1α,6β,7β,9α-tetrahydroxylabd-14-en-11-one. A carbonyl group links the 1-position hydroxy oxygen and the 9-position hydroxy oxygen to one another for forming a carbonate ester ring. Hydrogen is appended to the 6-position hydroxy oxygen. A hydrogen or an acetyl group is appended to the 7-position hydroxy oxygen.
提供了一种给药方法,其中将包含 forskolin 1α,9α-
碳酸化合物的组合物给药于人体受试者。根据一个实施例,forskolin 1α,9α-
碳酸化合物的骨架结构为 8,13-环氧-1α,6β,7β,9α-四羟基阿贝-14-烯-11-酮。一个羰基氧原子连接1位羟基氧原子和9位羟基氧原子以形成一个
碳酸酯环。6位羟基氧原子附加了氢。7位羟基氧原子附加了氢或乙酰基团。